Cite

HARVARD Citation

    Kelderman, S. et al. (n.d.). Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record